期刊文献+

配合物[Mn(EDTB)](NO_3)·_2DMF的合成、晶体结构及多酚氧化酶(PPO)活性的研究 被引量:6

Synthesis and Crystal Structure of Complex [Mn(EDTB)](NO_3)_2·DMF and Its Polyphenol Oxidase Activity
下载PDF
导出
摘要 合成六齿配体N,N,N′,N′-四(2-苯并咪唑亚甲基)-1,2-乙二胺(EDTB)及单核锰(Ⅱ)配合物[Mn(EDTB)](NO3)2.DMF,并进行了晶体结构和多酚氧化酶(PPO)模拟活性研究。该配合物为正交晶系,P212121空间群,a=1.172 52(6)nm,b=1.320 83(6)nm,c=2.461 91(12)nm,V=3.812 8(3)nm3,Dc=1.451 g.cm-3,Z=4,F(000)=1 732。最终因子R(I>2σ(I)):R1=0.052 2,wR2=0.102 2;R(全部数据):R1=0.0652,wR2=0.1075,Flack指数为0.02(15)。结构分析表明,锰(Ⅱ)分别与配体EDTB苯并咪唑环的4个氮原子、两个亚胺基氮原子发生配位,形成1个变形八面体结构。采用分光光度法研究配合物的多酚氧化酶活性,以邻苯三酚为底物,表明在0.1~10μmol.L-1范围内,随着配合物浓度逐渐增大,配合物的氧化促进率从51.5%增至82.2%。在30℃,pH=7.8~8.2条件下,配合物的转化数由22.93 h-1增加到51.01 h-1,说明配合物的PPO活性随着pH值的升高而明显增强。 The title complex [Mn(EDTB)](NO3)2·DMF [EDTB=N,N,N′,N′-tetrakis-[(2-benzimidazolyl) methyl]-1,2-ethanediamine] has been synthesized and characterized by elemental analysis and single crystal X-ray diffraction method.The crystal of mononuclear Mn(Ⅱ) complex belongs to orthorhombic crystal system with space group,P212121,a=1.172 52(6) nm,b=1.320 83(6) nm,c=2.461 91(12) nm,V=3.812 8(3) nm3,Dc=1.451 Mg·m-3,Z=4,F(000)=1 732.The final R(I2σ(I)):R1=0.052 2,wR2=0.102 2 and R(all data):R1=0.065 2,wR2=0.107 5,Flack parameter:0.02(15).The manganese(Ⅱ) atom of the cation has distorted octahedral coordination geometry and is six-coordinated by four nitrogen atoms of the benzimidazole groups and two tertiary amine nitrogen atoms from the ligand.Polyphenol oxidase activity toward pyrogallol has been studied spectroscop ically.In the 0.1~10 μmol·L-1 rang,promotion rates of the complex increase from 51.5% to 82.2%.The turnover numbers of the complex toward pyrogallol increase from 22.93 h-1 to 51.01 h-1 at 30 ℃,showing polyphenol oxidase activity of the complex increasing with pH.CCDC:771022.
出处 《无机化学学报》 SCIE CAS CSCD 北大核心 2011年第1期125-130,共6页 Chinese Journal of Inorganic Chemistry
基金 国家自然科学基金(No.21001047) 深圳微生物基因工程重点实验室开放基金资助项目
关键词 锰(Ⅱ)配合物 EDTB 晶体结构 PPO活性 manganese(Ⅱ) complex EDTB crystal structure polyphenol oxidase activity
  • 相关文献

参考文献14

  • 1Qiu J H, Liao Z R, Meng X G, et al. Polyhedron, 2005,24: 1617-1623.
  • 2Klabunde T, Eicken C, Sacchettini J C, et al. Nat. Struct. Biol., 1998,5:1084-1090.
  • 3LIZhong-Guang(李忠光) GONGMing(龚明).Yunnan Shifan Daxue Xuebao,2005,25:44-49.
  • 4DAIYa(戴亚) SHIChun-Hua(施春华) TANGHong(唐宏).Zhongguo Yancao Xuebao,2001,7(4):7-12.
  • 5HUANGJian-Shao(黄建韶) ZHANGHong(张洪) TIANHong-Xian(田红现).Shipin Yu Jixie,2001,83:21-22.
  • 6Qin S D, Feng S S, Zhang H M, et al. Acta Crystallogr., 2004,E60:o1121-o1122.
  • 7Hendriks H M J, Birker PJ M W L, van Rijn J. J. Am. Chem. Soc., 1982,104:3607-3617.
  • 8WUHong-Mei(吴红梅) XIAOHui(萧慧) LIGang(刘刚) etal.Chaye Tongbao,2004,26(2):62-64.
  • 9Li Q X, Luo Q H, Li Y Z, et al. Eur. J. Inorg. Chem., 2004: 4447-4456.
  • 10Liao Z R, Zheng X F, Luo B S, et al. Polyhedron, 2001,20: 2813-2821.

二级参考文献14

  • 1廖展如,姚锦,刘长林,石巨恩.一类新的超氧化物歧化酶的模型化合物[J].华中师范大学学报(自然科学版),1993,27(4):474-478. 被引量:2
  • 2Sawyer, D. T.; Valentine, J. S. Acc. Chem. Res. 1981, 14,393.
  • 3Youn, H.-D.; Kim, E.-J.; Roe, J.-H.; Hah, Y. C.; Kang, S.-O.Biochem. J. 1996, 318, 889.
  • 4Liao, Z.-R.; Zheng, X.-F.; Luo, B.-S.; Shen, L.-R.; Li, D.-F.;Liu, H.-L.; Zhao, W. Polyhedron 2001, 20, 2813.
  • 5Qin, S.-D.; Feng, S.-S.; Zhang, H.-M.; Yang, P.; Zhu, M.-L.Acta Crystallogr. 2004, E60, o1121.
  • 6Marklund, S.; Marklund, G. Eur. J. Biochem. 1974, 47, 469.
  • 7Magnani, L.; Gaydou, E. M.; Hubaud, J. G. Anal. Chim.Acta 2000, 441, 209.
  • 8Hendriks, H. M. J.; Birker, P. J. M. W. L.; Rijn, J. V.; Verschoor, G. C.; Reedijk, J. J. Am. Chem. Soc. 1982, 104,3607.
  • 9Stephen, D. H.; Brain, P. Polyhedron 1987, 6, 1457.
  • 10Liu, Y.-C.; Ma, J.-F.; Hu, N.-H.; Jia, H.-Q. Acta Crystallogr. 2003, E59, m361.

共引文献21

同被引文献95

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部